Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 103 of 103 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients | NCT03193086 | Glostrup University Hospital, Copenhagen | user2@example.com | None | 2017-01-01 | 2020-03-31 | 2021-03-31 | - | - | 2025-07-14 |
| Treatment of Urinary Incontinence in Women With Spinal Cord Injury | NCT02427230 | Glostrup University Hospital, Copenhagen | user2@example.com | None | 2015-05-31 | 2017-03-31 | 2018-03-31 | - | - | 2025-07-14 |
| Parents in Transition - a Nurse-led Support and Transfer Education Program | NCT04969328 | Glostrup University Hospital, Copenhagen | user2@example.com | None | 2021-07-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |